Table 1

 Demographic and clinical data and liver and renal function tests at the time of listing for transplantation in the 308 patients included in the study

INR, international normalisation ratio; MELD, model for end-stage liver disease; SBP, spontaneous bacterial peritonitis.
Data are expressed as as number (%) or mean (SD) (ranges)
*Other causes of end-stage liver disease were: cholestatic liver disease in 25 patients (8%), metabolic liver disease in 12 patients (4%), cryptogenic cirrhosis in 5 patients (2%), autoimmune liver disease in 3 patients (1%) and Budd–Chiari in 2 patients (1%).
†As defined by serum creatinine ⩾1.5 mg/dl.
‡All 20 patients had type 2 hepatorenal syndrome.
§To convert mg/dl into μmol/l multiply by 17.1.
¶To convert mg/dl into μmol/l multiply by 16.6.
Age (years)52 (9) (18–66)
Sex
    Male207 (67%)
    Female101 (33%)
Aetiology of cirrhosis
    Hepatitis C136 (44%)
    Alcohol80 (26%)
    Hepatitis C and alcohol25 (8%)
    Hepatitis B20 (6%)
    Other*47 (18%)
Complications of cirrhosis
    Ascites271 (88%)
        Controlled112 (41%)
        Uncontrolled159 (59%)
    Hepatic encephalopathy145 (47%)
    Variceal bleeding91 (29%)
    SBP83 (27%)
Renal failure†39 (13%)
    Hepatorenal syndrome‡20 (7%)
    Parenchymal renal disease19 (6%)
Bilirubin (mg/dl)§4.3 (5) (0.2–46)
Albumin (g/l)30 (5) (17–45)
Prothrombin time
    Ratio54 (16) (14–100)
    INR1.5 (0.8) (1–12)
Creatinine (mg/dl)¶1.2 (0.9) (0.3–11)
Sodium (mEq/l)135 (5) (111–146)
MELD score18 (5) (7–48)
Child–Pugh score9.3 (1.8) (5–15)